WebOct 22, 2024 · (Reuters) - Bristol Myers Squibb Co has expressed interest in buying autoimmune disease drug developer Aurinia Pharmaceuticals Inc, Bloomberg News reported on Friday, citing people familiar with the matter. Aurinia's shares closed up nearly 27% on the news, giving it a market capitalization of $3.59 billion, according to Refinitiv … WebThe Baumholder Army Health Clinic provides quality ambulatory care for Soldiers and their families while coordinating and facilitating inpatient and specialty care with our host …
Breaking News: BMY, AUPH latest news. - The Fly
WebApr 11, 2024 · 5 equities research analysts have issued 1-year target prices for Aurinia Pharmaceuticals' stock. Their AUPH share price forecasts range from $11.00 to $14.00. On average, they anticipate the company's stock price to reach $12.50 in the next year. This suggests a possible upside of 21.1% from the stock's current price. WebOct 23, 2024 · No final decision has been made and Bristol-Myers could opt against any potential deal, they said. Aurinia rose 27% to close at $28.00 in New York on Friday, … gooseneck gourds for sale
BMY - PFE Approvazione FDA APPROVATO - FinanzaNoStop
WebApr 13, 2024 · AUPH received an overall rating of 66, which means that it scores higher than 66% of stocks. Additionally, Aurinia Pharmaceuticals Inc scored a 70 in the … WebNov 22, 2024 · That’s well above the company’s daily average trading volume of 4.4 million shares. AUPH stock is down 29% as of Monday afternoon but is up 47.8% since the start of the year. Investors seeking ... WebOct 22, 2024 · Bristol-Myers Squibb (NYSE: BMY) has expressed interest in acquiring Aurinia Pharmaceuticals (NASDAQ: AUPH), according to Bloomberg, citing people … gooseneck full tilt trailer